Nonalcoholic Fatty Liver Disease Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Nonalcoholic Fatty Liver Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

FibrosisNonalcoholic SteatohepatitisNonalcoholic Fatty Liver Disease+1 more
Peking Union Medical College Hospital200 enrolled1 locationNCT05330923
Recruiting

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

HealthyObesity, OverweightChronic Kidney Disease+3 more
Chang Gung Memorial Hospital6,266 enrolled1 locationNCT07248371
Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis+4 more
Beijing Tsinghua Chang Gung Hospital4,000 enrolled1 locationNCT07070362
Recruiting
Phase 4

Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD

Type2 Diabetes MellitusNonalcoholic Fatty Liver Disease
Zhujiang Hospital100 enrolled1 locationNCT06449833
Recruiting

Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program

NAFLD (Nonalcoholic Fatty Liver Disease)PrediabetesDiabetes Mellitus Type 2, Diabetes Mellitus Type 1
Dasman Diabetes Institute2,000 enrolled1 locationNCT06115876
Recruiting

Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus

Type 2 Diabetes MellitusNonalcoholic Fatty Liver Disease
King Saud University1,000 enrolled1 locationNCT05697991
Recruiting

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies

Liver CancerObesityMetabolic Syndrome+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5,000 enrolled1 locationNCT04371042